These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3063783)

  • 41. Age-related hypotensive effect of placebo and active treatment in patients older than 60 years. European Working Party on High Blood Pressure in the Elderly.
    Thijs L
    Am J Med; 1991 Mar; 90(3A):24S-26S. PubMed ID: 2006656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of life and antihypertensive drugs in the elderly.
    Fletcher A; Bulpitt C
    Aging (Milano); 1992 Jun; 4(2):115-23. PubMed ID: 1504127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Propranolol, triamteren and hydrochlorothiazide in fixed combinations in the treatment of hypertension (author's transl)].
    Herrmann JM; Hiemstra S; Hoenig B
    Dtsch Med Wochenschr; 1981 Sep; 106(36):1138-43. PubMed ID: 7261940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe.
    Stein CM; Neill P; Mwaluko GM; Kusema T
    S Afr Med J; 1990 Mar; 77(5):243-5. PubMed ID: 2107581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Systolic hypertension in the elderly: Chinese trial (syst-China). Interim report].
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Oct; 20(5):270-5, 323. PubMed ID: 1306814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
    Düsing R; Kramer HJ
    Dtsch Med Wochenschr; 1977 Oct; 102(43):1541-6. PubMed ID: 913294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cross-over study on therapy indicators and blood pressure lowering action of beta-receptor blocker atenolol and the diuretic combination triamterene/hydrochlorothiazide].
    Walter U; Cordes U; Philipp T; Distler A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():311-4. PubMed ID: 347804
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STOP-Hypertension--preliminary communication from the pilot study of the Swedish Trial in Old Patients with Hypertension.
    Dahlöf B; Hansson L; Lindholm L; Schersten B; Wester PO
    J Hypertens Suppl; 1987 Dec; 5(5):S607-10. PubMed ID: 2895171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Systolic hypertension in the elderly: Chinese trial (Syst-China)--second interim report].
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun; 21(3):135-7, 185. PubMed ID: 8243223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results of clinical trials regarding the efficacy of treating hypertension.
    Borhani NO
    Clin Geriatr Med; 1989 Nov; 5(4):675-90. PubMed ID: 2691058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly.
    Fletcher A; Amery A; Birkenhäger W; Bulpitt C; Clement D; de Leeuw P; Deruyterre ML; de Schaepdryver A; Dollery C; Fagard R
    J Hypertens; 1991 Mar; 9(3):225-30. PubMed ID: 1851785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results of treatment of the elderly hypertensive.
    Moser M
    Geriatrics; 1989 Oct; 44 Suppl B():30-6. PubMed ID: 2680778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60.
    Amery A; Birkenhäger W; Brixko R; Bulpitt C; Clement D; Deruyttere M; De Schaepdryver A; Dollery C; Fagard R; Forette F
    Lancet; 1986 Sep; 2(8507):589-92. PubMed ID: 2875317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF; Bulpitt CJ; Fletcher AE
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metoprolol or hydrochlorothiazide in patients with hypertension aged 60-75 years. With special reference to assessment of compliance. Hunter Hypertension Research Group.
    Med J Aust; 1986 Nov; 145(10):521-3. PubMed ID: 2877386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Further learnings from the European Working Party on High Blood Pressure in the Elderly (EWPHE) study: focus on systolic hypertension.
    O'Malley K; Cox JP; O'Brien E
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1249-51. PubMed ID: 2009248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of isolated systolic hypertension in the elderly.
    Staessen J; Dekempeneer L; Fagard R; Guo CY; Thijs L; van Hoof R; Amery A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S34-40. PubMed ID: 1723453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.